VFA
RKDA icon

Valeo Financial Advisors’s Arcadia Biosciences RKDA Stock Holding History

Valeo Financial Advisors’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-30
Closed -$5K – 1688
2018
Q3 		$5K Buy
30
+22
+275% +$5.53K ﹤0.01% 1218
2018
Q2 		$2K Buy
+8
New +$4.37K ﹤0.01% 1373

Other funds holding RKDA

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return

Valeo Financial Advisors's RKDA Position: Q4 2018 in Review

Valeo Financial Advisors sold out of Arcadia Biosciences (RKDA) in Q4 2018, closing a stake of 30 shares — an estimated $5K sold.

Valeo Financial Advisors first reported a position in RKDA in Q2 2018 and held it in 2 quarters. The position peaked at $5K in Q3 2018. 11 funds tracked by Wall St. Rank hold RKDA as of Q4 2018.

  • Valeo Financial Advisors reported no remaining Arcadia Biosciences position as of Q4 2018 after selling out during the quarter.
  • Valeo Financial Advisors sold 30 Arcadia Biosciences shares in Q4 2018, an estimated $5K.
  • Valeo Financial Advisors first reported a position in Arcadia Biosciences in Q2 2018 and held it in 2 quarters.
  • Valeo Financial Advisors's Arcadia Biosciences position peaked at $5K in Q3 2018.
  • 11 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q4 2018.

Based on Valeo Financial Advisors's 13F filing for Q4 2018, filed 30 Jan 2019.